Skip the wait and schedule your appointments online or through MyChart.

COVID Vaccine Now Available for Ages 6 months+ – Learn More

Research & Innovation

DEFINE AFib

Clinical Trials

DEFINE AFib

Physician & Study Coordinator

Close

Synopsis

Synopsis: DEFINE AFib is a prospective, observational, post-market clinical study administered to patients via the Medtronic Discovery app platform. The Study App is designed to easily collect data using an iPhone® and is built using the Apple® ResearchKit® framework. Interested participants will be screened through the Medtronic Discovery app and those eligible will complete an app-based informed consent. Participants will receive health-focused and quality of life surveys at variable timepoints. DEFINE AFib will measure healthcare interactions using administered surveys to identify said interactions. The Medtronic Discovery app will provide participants with a summary of their ICM data. Participants will be followed up to 5 years or to the end of their ICM service life.

Close

Eligibility Criteria

Inclusion Criteria

Patients with a LINQ ICM who have a self-reported history of AF and who have received an ICM for the following device-logged indications, categorized into the following discrete groups:

  • Stroke: Cryptogenic stroke indication
  • AF management: AF management and post-ablation management indications
  • Suspected AF: Suspected AF and palpitations indications
  • Individual Access and ability to use an Apple iPhone® compatible with Medtronic's research app (iOS® v. 13.X or higher)
  • Patient is 22 years of age or older
  • Located in the United States, with CareLink managed through servers located in United States (50 states or District of Columbia)
  • Valid email address from self-report at enrollment
  • Patient must be able to read and write in English

Close